Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other hematologic neoplasm 1Lymphoid 1Dermatologic 1Breast 1

Conditions

Lymphoma 4Lymphoma, Non-Hodgkin 3Leukemia 3Hematologic Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Myelodysplastic Syndromes 2Multiple Myeloma 2Leukemia, Myeloid, Acute 2Philadelphia Chromosome 1Neoplasm, Residual 1Lymphoma, B-Cell 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Hairy Cell 1Leukemia, B-Cell 1Hodgkin Disease 1Cardiotoxicity 1Burkitt Lymphoma 1Bronchiolitis Obliterans Syndrome 1

Interventions

Doxorubicin 2hydrocortisone hemisuccinate 1Vincristine 1Razoxane 1Radiotherapy 1Prednisone 1Methotrexate 1Mercaptopurine 1Medical History Taking 1Leucovorin 1Laser-Doppler Flowmetry 1Hydrocortisone 1Exercise 1Electrocardiography 1Echocardiography, Stress 1Dexrazoxane 1Cytarabine 1Blood Cell Count 1Asparaginase 1Anthropometry 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cardiotoxicity × Electrocardiography × Other hematologic neoplasm × Clear all
NCT05703126 2024-11-05

Clinical and Diagnostic Significance of Endothelial Dysfunction and Myocardial Contractility in Patients With AML

Samara State Medical University

Phase NA Recruiting
100 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡